| S1548 |
Dapagliflozin |
Dapagliflozin is a potent and selective hSGLT2 inhibitor with EC50 of 1.1 nM, exhibiting 1200-fold selectivity over hSGLT1. Phase 4. |
Selective |
hSGLT2, EC50: 1.1 nM |
| S2760 |
Canagliflozin |
Canagliflozin is a highly potent and selective SGLT2 inhibitor for hSGLT2 with IC50 of 2.2 nM, exhibits 413-fold selectivity over hSGLT1. |
Selective |
mSGLT2, IC50: 2 nM; rSGLT2, IC50: 3.7 nM; hSGLT2, IC50: 4.4 nM |
| S8022 |
Empagliflozin (BI 10773) |
Empagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3. |
Selective |
SGLT2, IC50: 3.1 nM |